Spyre Therapeutics, Inc.

STATE STREET CORP SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

195,089

Value ($000)

88

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	88	0.0%	195,089	6/30/2023
2023 Q1	5/15/2023	62	0.0%	214,989	3/31/2023
2022 Q4	5/15/2023	97	0.0%	214,989	12/31/2022
2022 Q3	11/15/2022	84	0.0%	158,989	9/30/2022
2022 Q2	8/15/2022	80	0.0%	158,989	6/30/2022
2022 Q1	5/16/2022	1,810	0.0%	787,048	3/31/2022
2021 Q4	2/14/2022	3,601	0.0%	758,041	12/31/2021
2021 Q3	11/15/2021	6,097	0.0%	766,941	9/30/2021
2021 Q2	8/16/2021	5,272	0.0%	757,500	6/30/2021
2021 Q1	7/9/2021	5,690	0.0%	718,475	3/31/2021
2020 Q4	2/16/2021	5,724	0.0%	727,334	12/31/2020
2020 Q3	11/10/2020	4,657	0.0%	656,851	9/30/2020
2020 Q2	8/14/2020	6,038	0.0%	652,803	6/30/2020
2020 Q1	6/19/2020	2,198	0.0%	471,698	3/31/2020
2019 Q4	2/6/2020	3,551	0.0%	464,799	12/31/2019